Medytox Inc.


Based on integrity and open communication, Medytox is building excellent capacity
and system to meet the global standard with commitment and courage.
Furthermore, we are endeavoring to reach $1 billion in sales, $10 billion in market value,
and to become one of the world’s top 20 biopharmaceutical companies by 2022.“

*Textauszug aus http://www.medytox.com